We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+16.82%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$37M
Cap. Flow
-$42.8M
Cap. Flow %
-37.45%
Top 10 Hldgs %
55.88%
Holding
85
New
18
Increased
11
Reduced
34
Closed
19

Top Buys

Rank Stock Value
1
ARCT icon
Arcturus Therapeutics
ARCT
+$3.67M
2
FLNA
Filana Therapeutics
FLNA
+$3.22M
3
CYNI
CYAN INC COM
CYNI
+$2.12M
4
BEAT
BioTelemetry, Inc.
BEAT
+$2.04M
5
MNDT
Mandiant, Inc. Common Stock
MNDT
+$1.32M

Top Sells

Rank Stock Value
1
SIGA icon
SIGA Technologies
SIGA
+$4.46M
2
AVAV icon
AeroVironment
AVAV
+$4.42M
3
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$4.02M
4
CALX icon
Calix
CALX
+$3.41M
5
SANW
S&W Seed Co
SANW
+$3.17M

Sector Composition

Rank Sector Weight
1 Healthcare 55.14%
2 Technology 27.01%
3 Communication Services 7.3%
4 Utilities 3.88%
5 Miscellaneous 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSEM icon
76
Tower Semiconductor
TSEM
$24.8B
– –
-115,559
Closed -$563K
PSIX
77
Power Solutions International
PSIX
$871M
– –
-10,000
Closed -$591K
TIVO
78
DELISTED
Tivo Inc
TIVO
– –
-25,000
Closed -$479K
EXAC
79
DELISTED
Exactech Inc
EXAC
– –
-33,700
Closed -$679K
OME
80
DELISTED
Omega Protein
OME
– –
-11,800
Closed -$120K
OKS
81
DELISTED
Oneok Partners LP
OKS
– –
-1,400
Closed -$74K
RGDX
82
DELISTED
RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
– –
-487,805
Closed -$1.08M
ZGNX
83
DELISTED
Zogenix, Inc.
ZGNX
– –
-50,750
Closed -$753K
RPRX
84
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-93,300
Closed -$2.5M
CERE
85
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
– –
-3,125
Closed -$37K
1 2 3
4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Sophrosyne Capital held 85 positions worth $114M, down 24% from $151M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sophrosyne Capital withdrew a net $42.8M in Q4 2013, closing 19 positions and reducing 34 holdings. Its most notable exit was SIGA Technologies, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 50% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Sophrosyne Capital opened a new position in CYAN INC COM worth $1.88M.

  • Sophrosyne Capital's largest Q4 2013 buy was CYAN INC COM: 354,699 shares worth $1.88M.
  • Sophrosyne Capital added most to Arcturus Therapeutics in Q4 2013, an estimated $3.67M increase.
  • Sophrosyne Capital's biggest Q4 2013 reduction was AeroVironment, cutting an estimated $4.42M.
  • Sophrosyne Capital fully exited SIGA Technologies in Q4 2013, selling an estimated $4.46M.
  • Sophrosyne Capital's ten largest holdings make up 56% of its $114M portfolio in Q4 2013.
  • Sophrosyne Capital opened 18 new positions and closed 19 in Q4 2013.
  • Sophrosyne Capital's portfolio value fell 24% quarter-over-quarter to $114M.

Based on Sophrosyne Capital's 13F filing for Q4 2013, filed 13 Feb 2014.